NCT00663728View on ClinicalTrials.gov

Assessment of Duration of Erection With Vardenafil 10 mg

PHASE4CompletedINTERVENTIONAL
Enrollment

201

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

April 30, 2005

Study Completion Date

April 30, 2005

Conditions
Erectile Dysfunction
Interventions
DRUG

Levitra (Vardenafil, BAY38-9456)

10mg Vardenafil taken orally 1 hour prior to sexual intercourse

DRUG

Placebo

Matching placebo

Sponsors

Lead Sponsor

Bayer

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

Bayer

INDUSTRY

NCT00663728 - Assessment of Duration of Erection With Vardenafil 10 mg | Biotech Hunter | Biotech Hunter